Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trialCaicun Zhou, Jianjun Zou, Yunpeng Liu et al.|The Lancet Respiratory Medicine|2020Cited by 504
Tanshinone IIA combined with cisplatin synergistically inhibits non‐small‐cell lung cancer in vitro and in vivo via down‐regulating the phosphatidylinositol 3‐kinase/Akt signalling pathwayXiaozhong Liao, Lizhu Lin|Phytotherapy Research|2019Cited by 64
Negative association of C-reactive protein-albumin-lymphocyte index (CALLY index) with all-cause and cause-specific mortality in patients with cancer: results from NHANES 1999–2018Di Zhu, Lizhu Lin, Ye-Ding Lin et al.|BMC Cancer|2024Cited by 45
RETRACTED ARTICLE: Tiliroside as a CAXII inhibitor suppresses liver cancer development and modulates E2Fs/Caspase-3 axisRui Han, Lizhu Lin|Scientific Reports|2021Cited by 42
Expert consensus on treatment for stage III non‐small cell lung cancerYi‐Long Wu, Yun Fan, Shun Lü et al.|Medicine Advances|2023Cited by 18